Search for Distinctive Markers in DNT and Cortical Grade II Glioma in Children: Same Clinicopathological and Molecular Entities?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|12|15|1683-1692

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.12, Iss.15, 2012-08, pp. : 1683-1692

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular and clinicopathological markers of prognosis in breast cancer

By Boyle David P McCourt Clare M Matchett Kyle B Salto-Tellez Manuel

Expert Review of Molecular Diagnostics, Vol. 13, Iss. 5, 2013-06 ,pp. : 481-498

Informa Healthcare

Access to resources Recommend Favorite

Cytotoxic and molecular chemotherapy for high-grade glioma: an emerging strategy for the future

By Cavaliere Robert Newton Herbert

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 749-765

Informa Healthcare

Access to resources Recommend Favorite

Current and future directions for Phase II trials in high-grade glioma

By Alexander Brian M Lee Eudocia Q Reardon David A Wen Patrick Y

Expert Review of Neurotherapeutics, Vol. 13, Iss. 4, 2013-04 ,pp. : 369-387

Informa Healthcare

Access to resources Recommend Favorite

Phase II Study of Antineoplaston A10 and AS2-1 in Children with Recurrent and Progressive Multicentric Glioma: A Preliminary Report

By Stanislaw R. Burzynski

Drugs in R&D, Vol. 5, Iss. 6, 2004-01 ,pp. : 315-326

Adis International

Access to resources Recommend Favorite

Targeting ErbB Receptors in High-Grade Glioma

Current Pharmaceutical Design, Vol. 17, Iss. 23, 2011-08 ,pp. : 2468-2487

Bentham Science Publishers

Access to resources Recommend Favorite